Systemic lupus erythematosus progressing to non-Hodgkin's lymphoma complicated by fatal hemophagocytic syndrome: Case report

Acta Dermatovenerologica Croatica

Volumn 20, Issue 1, 2012, Pages 21-26

  Jeremić, Ivica ^a   Dordević Kontić, Slobodanka ^a   Nikolić, Miloš ^a   Šefik Bukilica, Mirjana ^a   Vujasinović Stupar, Nada ^a   Bonači Nikolić, Branka ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Hemophagocytic syndrome; Lymphoma; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; CHLOROQUINE; COLECALCIFEROL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUCONAZOLE; GLUCOCORTICOID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CAUSE OF DEATH; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DYSPNEA; FATIGUE; FEMALE; FEVER; GANGRENE; HEART RATE; HEMOPHAGOCYTIC SYNDROME; HEMOPTYSIS; HISTIOCYTOSIS; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; LIVEDO RETICULARIS; LUNG INFILTRATE; MACROPHAGE ACTIVATION SYNDROME; MOUTH ULCER; NONHODGKIN LYMPHOMA; PALLOR; PANCYTOPENIA; PNEUMONIA; RASH; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYPNEA; VISUAL IMPAIRMENT; VITAMIN D DEFICIENCY; WEIGHT REDUCTION;

DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA, NON-HODGKIN; MIDDLE AGED;

EID: 84859739094     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Janka GE. Familial and acquired haemophagocytic lymphohistiocytosis. Eur J Pediatr 2007;166:95-109.
2. Qian J, Yang CD. Haemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol 2007;26:807-10.
3. Löfström B, Backlin C, Sundström C, Ekbom A, Lundberg IE. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis 2007;66:1627-32.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
5. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
6. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
7. Zaharopoulos P. Serous fluid cytology as a means of detecting haemophagocytosis in Epstein-Barr virus-induced autoimmune hemolytic anemia. Diagn Cytopathol 2001;25:248-52.
8. Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol 2005;141:65-173.
9. Carvalheiras G, Anjo D, Mendonça T, Vasconcelos C, Farinha F. Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus-case report and literature review. Lupus 2010;19:756-61.
10. Genvresse I, Lüftner D, Späth-Schwalbe E, Buttgereit F. Prevalence and clinical significance of anticardiolipin and antibeta 2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. Eur J Haematol 2002;68:84-90.
11. Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004;104:2247-53.
12. Helming L, Böse J, Ehrchen J, Schiebe S, Frahm T, Geffers R et al. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005;106:4351-8.
13. Defacque H, Piquemal D, Basset A, Marti J, Commes T. Transforming growth factor-beta1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. J Cell Physiol 1999;178:109-19.
14. Raina V, Cunningham D, Gilchrist N, Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 1991;63:463-5.
15. Machaczka M, Vaktnas J. Haemophagocytic syndrome associated with Hodgkin lymphoma and Pneumocystis jirovecii pneumonitis. Br J Haematol 2007;138:672.